$PSGR Do you ever watch the old 50s and 60s shows on TV?
$PSGR Do you ever watch the old 50s and 60s shows on TV? You know the ones: a Hero who always places himself in the face of DANGER!
The Hero is critically wounded and brought to a hospital. The Medical Staff surrounds the gurney while one bright, good looking young doctor takes charge. "It looks like a Level 47 trauma to the left ventricular subdermal mitochondria!!!! We have to act fast. Get the Hero on a heart monitor."
Bing....bing.....bing.....bing.......zyzyzyzyzyzyzyz. "The Hero's heart stopped....quick nurse, get the defibrulator!"
ZZZZZZZZAAAAAPPPPP!!! "It's NOT BEATING!!!!!!!
The young doctor then jumps up on the gurney and straddles the Hero. He begins beating on the chest. NOTHING. "Quick, Nurse, get me the BIGGEST F'ing syringe in the world and fill it with 6,000 ML of adrenaline solution!"
The medical staff circles and begins whispering "It won't work! It will surely kill the Hero!" But they do not interfere with the young Doctor!
The nurse hands the Doctor a 55 gallon syringe with 3 feet long needle and the Doctor plunges the needle into the Hero's heart!
Zyzyzyzyzyzy.."IT'S NOT WORKING!!!! Nurse, GET ME A SET OF TRUCK JUMPER CABLES AND I WILL STICK MY FINGERS INTO THIS 220 VOLT WALL SOCKET. THAT SHOULD PROVIDE ENOUGH OF A JOLT TO START THE HERO'S HEART!!!!"
We all know that the story will have a happy ending. The Hero will make a miraculous recovery when he feels the tears of his 32 year old Golden Retriever hit his chest. We know the storyline is all BS, but it is entertaining...fun.
Yeah, this little story is a FUN Make-Believe Story with actors with whom the viewers identify. However, on the other hand, Pershing Resources is a real live story that has not had a Happy Ending for OVER TWENTY YEARS. The characters/actors in the TV Show are scripted to be either likeable or villains. The employees/representatives of Pershing Resources are real life people who are in it for themselves NOT to entertain shareholders. A Happy Ending is NOT a Press Release that states something MAY occur in some distant time period. TV shows got cancelled when the viewers tired of the same old story over and over again. Judging by the lack of interest in the purchase of PSGR shares, investors are VERY tired of the same old story, over and over again!
Pershing Resources Company Inc. (PSGR) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...
Continue Reading
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...
Continue Reading
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Top 5 Most Recently Viewed Articles
Chart Industries Announces Leadership Change Chart Industries (NYSE: GTLS) is taking significant steps toward a future transition as CEO Jill Evanko has announced plans to assume a senior advisor role starting in early 2026. This change comes as she prepares to take on a new executive opportunity within a privately owned company. Evanko has been essential in steering the...
Continue Reading
Understanding Debtors: Key Insights from Realkredit Danmark A/S At the heart of any effective financial institution is a reliable understanding of its debtors. Realkredit Danmark A/S, a prestigious name in the financial landscape, recently made available a detailed breakdown of its debtors. This information is crucial for various stakeholders, including investors,...
Continue Reading
Bitcoin's Recent Performance The cryptocurrency market has been lively lately, especially with Bitcoin recently falling below the $59,000 threshold. Investors had been optimistic, especially since the cryptocurrency saw a remarkable $436 million in net ETF inflows just last week. This significant influx signals that institutional interest in cryptocurrencies is still...
Continue Reading
Introduction to The Emily Program and ARFID The Emily Program is making significant strides in specialized care for individuals with Avoidant/Restrictive Food Intake Disorder (ARFID). This condition, often misunderstood, has recently begun to garner more attention from healthcare experts. In response to this need, The Emily Program is offering advanced treatment...
Continue Reading
Overview of Legal Actions Against 3D Systems Corporation Recently, investors in 3D Systems Corporation have found themselves entangled in a potential securities fraud lawsuit. This case serves as a cautionary tale, highlighting the importance of transparency and integrity in corporate communication. The allegations stem from assertions that the company made misleading...
Continue Reading